Resmed Inc. Stock
Price
Target price
€162.10
€162.10
-3.410%
-5.7
-3.410%
€259.74
17.06.26 / Tradegate
WKN: 895878 / Symbol: RMD / Name: ResMed / Stock / Healthcare Equipment & Supplies / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Resmed Inc. Stock
Resmed Inc. took a tumble today and lost -€5.700 (-3.410%).
Resmed Inc. is currently one of the favorites of our community with 19 Buy predictions and no Sell predictions.
As a result the target price of 259 € shows a very positive potential of 59.78% compared to the current price of 162.1 € for Resmed Inc..
Pros and Cons of Resmed Inc. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
M***** P*******
Cons
?
C******** o* t** e**********
?
S********** s********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Resmed Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Resmed Inc. | -3.410% | -3.397% | -6.732% | -25.574% | -22.254% | -19.112% | -19.832% |
| Veeva Systems A | -4.160% | -5.072% | -1.426% | -45.090% | -29.634% | -26.366% | -47.466% |
| Thermo Fisher Scientific Inc. | -1.570% | -3.854% | 6.523% | 18.217% | -18.717% | -18.237% | -1.616% |
| Boston Scientific | -2.930% | -6.638% | -13.753% | -55.869% | -51.966% | -21.280% | 7.359% |
Comments
ResMed (RMD) had its price target lowered by Citigroup Inc. to $270.00. They now have a "buy" rating on the stock.
Show more
Ratings data for RMD provided by MarketBeat
ResMed (RMD) is now covered by JPMorgan Chase & Co.. They set an "overweight" rating on the stock.
Show more
Ratings data for RMD provided by MarketBeat
ResMed (RMD) was given a new $255.00 price target by Evercore Inc. They now have an "outperform" rating on the stock.
Show more
Ratings data for RMD provided by MarketBeat